Induced pluripotent stem cells model personalized variations in liver disease resulting from α1-antitrypsin deficiency.

ABSTRACT:

Unlabelled

In the classical form of α1-antitrypsin deficiency (ATD), aberrant intracellular accumulation of misfolded mutant α1-antitrypsin Z (ATZ) in hepatocytes causes hepatic damage by a gain-of-function, "proteotoxic" mechanism. Whereas some ATD patients develop severe liver disease (SLD) that necessitates liver transplantation, others with the same genetic defect completely escape this clinical phenotype. We investigated whether induced pluripotent stem cells (iPSCs) from ATD individuals with or without SLD could model these personalized variations in hepatic disease phenotypes. Patient-specific iPSCs were generated from ATD patients and a control and differentiated into hepatocyte-like cells (iHeps) having many characteristics of hepatocytes. Pulse-chase and endoglycosidase H

SUBMITTER: Tafaleng EN 

PROVIDER: S-EPMC4482790 | biostudies-literature | 2015 Jul

REPOSITORIES: biostudies-literature